-
1
-
-
84872967522
-
Cancer statistics, 2013
-
Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1): 11-30.
-
(2013)
CA Cancer J Clin
, vol.63
, Issue.1
, pp. 11-30
-
-
Siegel, R.1
Naishadham, D.2
Jemal, A.3
-
2
-
-
84871036375
-
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010
-
[published correction appears in Lancet. 2013;381(9867): 628]
-
Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 [published correction appears in Lancet. 2013;381(9867): 628]. Lancet. 2012;380(9859): 2095-2128.
-
(2012)
Lancet
, vol.380
, Issue.9859
, pp. 2095-2128
-
-
Lozano, R.1
Naghavi, M.2
Foreman, K.3
-
3
-
-
79958043675
-
-
National Cancer Institute. Bethesda, MD, based on November 2012 SEER data submission, posted to the SEER web site, April 2013. Accessed June 10, 2013
-
Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2010, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975-2010/, based on November 2012 SEER data submission, posted to the SEER web site, April 2013. Accessed June 10, 2013.
-
SEER Cancer Statistics Review, 1975-2010
-
-
Howlader, N.1
Noone, A.M.2
Krapcho, M.3
Garshell, J.4
Neyman, N.5
Altekruse, S.F.6
Kosary, C.L.7
Yu, M.8
Ruhl, J.9
Tatalovich, Z.10
Cho, H.11
Mariotto, A.12
Lewis, D.R.13
Chen, H.S.14
Feuer, E.J.15
Cronin, K.A.16
-
4
-
-
84865987833
-
The influence of hispanic ethnicity on nonsmall cell lung cancer histology and patient survival: An analysis of the survival epidemiology and end results database
-
Saeed AM, Toonkel R, Glassberg MK, et al. The influence of Hispanic ethnicity on nonsmall cell lung cancer histology and patient survival: an analysis of the Survival, Epidemiology, and End Results database. Cancer. 2012;118(18): 4495-4501.
-
(2012)
Cancer
, vol.118
, Issue.18
, pp. 4495-4501
-
-
Saeed, A.M.1
Toonkel, R.2
Glassberg, M.K.3
-
5
-
-
84875278514
-
Cancer genes in lung cancer: Racial disparities: Are there any?
-
El-Telbany A, Ma PC. Cancer genes in lung cancer: racial disparities: are there any? Genes Cancer. 2012;3(7-8): 467-480.
-
(2012)
Genes Cancer
, vol.3
, Issue.7-8
, pp. 467-480
-
-
El-Telbany, A.1
Ma, P.C.2
-
6
-
-
79951761631
-
Frequency and type of epidermal growth factor receptor mutations in African Americans with non-small cell lung cancer
-
Cote ML, Haddad R, Edwards DJ, et al. Frequency and type of epidermal growth factor receptor mutations in African Americans with non-small cell lung cancer. J Thorac Oncol. 2011;6(3): 627-630.
-
(2011)
J Thorac Oncol
, vol.6
, Issue.3
, pp. 627-630
-
-
Cote, M.L.1
Haddad, R.2
Edwards, D.J.3
-
7
-
-
79954574430
-
Characterization of epidermal growth factor receptor mutations in non-small-cell lung cancer patients of African-American ancestry
-
Harada T, Lopez-Chavez A, Xi L, Raffeld M, Wang Y, Giaccone G. Characterization of epidermal growth factor receptor mutations in non-small-cell lung cancer patients of African-American ancestry. Oncogene. 2011;30(15): 1744-1752.
-
(2011)
Oncogene
, vol.30
, Issue.15
, pp. 1744-1752
-
-
Harada, T.1
Lopez-Chavez, A.2
Xi, L.3
Raffeld, M.4
Wang, Y.5
Giaccone, G.6
-
8
-
-
73949154122
-
Genetic abnormalities of the EGFR pathway in African American Patients with non-small-cell lung cancer
-
Leidner RS, Fu P, Clifford B, et al. Genetic abnormalities of the EGFR pathway in African American Patients with non-small-cell lung cancer. J Clin Oncol. 2009;27(33): 5620-5626.
-
(2009)
J Clin Oncol
, vol.27
, Issue.33
, pp. 5620-5626
-
-
Leidner, R.S.1
Fu, P.2
Clifford, B.3
-
9
-
-
78651087933
-
Frequency of EGFR and KRAS mutations in lung adenocarcinomas in African Americans
-
Reinersman JM, Johnson ML, Riely GJ, et al. Frequency of EGFR and KRAS mutations in lung adenocarcinomas in African Americans. J Thorac Oncol. 2011; 6(1): 28-31.
-
(2011)
J Thorac Oncol
, vol.6
, Issue.1
, pp. 28-31
-
-
Reinersman, J.M.1
Johnson, M.L.2
Riely, G.J.3
-
10
-
-
21244500107
-
Mutational analysis of EGFR and K-RAS genes in lung adenocarcinomas
-
Soung YH, Lee JW, Kim SY, et al. Mutational analysis of EGFR and K-RAS genes in lung adenocarcinomas. Virchows Arch. 2005;446(5): 483-488.
-
(2005)
Virchows Arch
, vol.446
, Issue.5
, pp. 483-488
-
-
Soung, Y.H.1
Lee, J.W.2
Kim, S.Y.3
-
11
-
-
79958178777
-
East meets West: Ethnic differences in epidemiology and clinical behaviors of lung cancer between East Asians and Caucasians
-
Zhou W, Christiani DC. East meets West: ethnic differences in epidemiology and clinical behaviors of lung cancer between East Asians and Caucasians. Chin J Cancer. 2011;30(5): 287-292.
-
(2011)
Chin J Cancer
, vol.30
, Issue.5
, pp. 287-292
-
-
Zhou, W.1
Christiani, D.C.2
-
12
-
-
33847091172
-
EGFR ERBB2 and KRAS Mutations in Korean Non-small Cell Lung Cancer Patients
-
Bae NC, Chae MH, Lee MH, et al. EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients. Cancer Genet Cytogenet. 2007; 173(2): 107-113.
-
(2007)
Cancer Genet Cytogenet
, vol.173
, Issue.2
, pp. 107-113
-
-
Bae, N.C.1
Chae, M.H.2
Lee, M.H.3
-
13
-
-
77955092984
-
Spectrum of LKB1, EGFR, and KRAS mutations in Chinese lung adenocarcinomas
-
Gao B, Sun Y, Zhang J, et al. Spectrum of LKB1, EGFR, and KRAS mutations in Chinese lung adenocarcinomas. J Thorac Oncol. 2010;5(8): 1130-1135.
-
(2010)
J Thorac Oncol
, vol.5
, Issue.8
, pp. 1130-1135
-
-
Gao, B.1
Sun, Y.2
Zhang, J.3
-
14
-
-
10844231985
-
Mutations of the epidermal growth factor receptor gene in lung cancer: Biological and clinical implications
-
Kosaka T, Yatabe Y, Endoh H, Kuwano H, Takahashi T, Mitsudomi T. Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications. Cancer Res. 2004;64(24): 8919-8923.
-
(2004)
Cancer Res
, vol.64
, Issue.24
, pp. 8919-8923
-
-
Kosaka, T.1
Yatabe, Y.2
Endoh, H.3
Kuwano, H.4
Takahashi, T.5
Mitsudomi, T.6
-
15
-
-
80054948914
-
Genotyping non-small cell lung cancer (NSCLC) in Latin America
-
Arrieta O, Cardona AF, Federico Bramuglia G, et al. Genotyping non-small cell lung cancer (NSCLC) in Latin America. J Thorac Oncol. 2011;6(11): 1955-1959.
-
(2011)
J Thorac Oncol
, vol.6
, Issue.11
, pp. 1955-1959
-
-
Arrieta, O.1
Cardona, A.F.2
Federico Bramuglia, G.3
-
16
-
-
84863980235
-
Epidermal growth factor receptor and KRAS mutations in Brazilian lung cancer patients
-
Bacchi CE, Ciol H, Queiroga EM, Benine LC, Silva LH, Ojopi EB. Epidermal growth factor receptor and KRAS mutations in Brazilian lung cancer patients. Clinics (Sao Paulo). 2012;67(5): 419-424.
-
(2012)
Clinics (Sao Paulo)
, vol.67
, Issue.5
, pp. 419-424
-
-
Bacchi, C.E.1
Ciol, H.2
Queiroga, E.M.3
Benine, L.C.4
Silva, L.H.5
Ojopi, E.B.6
-
17
-
-
84858297956
-
The cost-effectiveness of screening lung cancer patients for targeted drug sensitivity markers
-
Atherly AJ, Camidge DR. The cost-effectiveness of screening lung cancer patients for targeted drug sensitivity markers. Br J Cancer. 2012;106(6): 1100-1106.
-
(2012)
Br J Cancer
, vol.106
, Issue.6
, pp. 1100-1106
-
-
Atherly, A.J.1
Camidge, D.R.2
-
18
-
-
69349083935
-
Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population
-
Rodig SJ, Mino-Kenudson M, Dacic S, et al. Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population. Clin Cancer Res. 2009;15(16): 5216-5223.
-
(2009)
Clin Cancer Res
, vol.15
, Issue.16
, pp. 5216-5223
-
-
Rodig, S.J.1
Mino-Kenudson, M.2
Dacic, S.3
-
19
-
-
70349336416
-
Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK
-
Shaw AT, Yeap BY, Mino-Kenudson M, et al. Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK. J Clin Oncol. 2009;27(26): 4247-4253.
-
(2009)
J Clin Oncol
, vol.27
, Issue.26
, pp. 4247-4253
-
-
Shaw, A.T.1
Yeap, B.Y.2
Mino-Kenudson, M.3
-
20
-
-
80053386829
-
Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: A retrospective analysis
-
Shaw AT, Yeap BY, Solomon BJ, et al. Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis. Lancet Oncol. 2011;12(11): 1004-1012.
-
(2011)
Lancet Oncol
, vol.12
, Issue.11
, pp. 1004-1012
-
-
Shaw, A.T.1
Yeap, B.Y.2
Solomon, B.J.3
-
21
-
-
84870858928
-
Lung cancer genotype-based therapy and predictive biomarkers: Present and future
-
Cagle PT, Allen TC. Lung cancer genotype-based therapy and predictive biomarkers: present and future. Arch Pathol Lab Med. 2012;136(12): 1482-1491.
-
(2012)
Arch Pathol Lab Med
, vol.136
, Issue.12
, pp. 1482-1491
-
-
Cagle, P.T.1
Allen, T.C.2
-
22
-
-
84860582939
-
Advances in treatment of lung cancer with targeted therapy
-
Cagle PT, Chirieac LR. Advances in treatment of lung cancer with targeted therapy. Arch Pathol Lab Med. 2012;136(5): 504-509.
-
(2012)
Arch Pathol Lab Med
, vol.136
, Issue.5
, pp. 504-509
-
-
Cagle, P.T.1
Chirieac, L.R.2
-
23
-
-
84879635389
-
Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology [published online ahead of print April 3, 2013] doi:10.5858/arpa. 2012-0720-OA
-
Lindeman NI, Cagle PT, Beasley MB, et al. Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology [published online ahead of print April 3, 2013]. Arch Pathol Lab Med. doi:10.5858/arpa. 2012-0720-OA.
-
Arch Pathol Lab Med
-
-
Lindeman, N.I.1
Cagle, P.T.2
Beasley, M.B.3
-
24
-
-
0003809054
-
-
American Joint Committee On CancerLung. 6th ed. New York, NY: Springer- Verlag;. Accessed March 5 2013
-
American Joint Committee on CancerLung. In: Greene FL, Page DL, Fleming ID, eds. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer- Verlag; 2002: 167-177. http://www.cancerstaging.org/products/csmanual6ed-3. pdf. Accessed March 5, 2013.
-
(2002)
AJCC Cancer Staging Manual
, pp. 167-177
-
-
Greene, F.L.1
Page, D.L.2
Fleming, I.D.3
-
26
-
-
33751084640
-
PIK3CA mutation status in Japanese lung cancer patients
-
Kawano O, Sasaki H, Endo K, et al. PIK3CA mutation status in Japanese lung cancer patients. Lung Cancer. 2006;54(2): 209-215.
-
(2006)
Lung Cancer
, vol.54
, Issue.2
, pp. 209-215
-
-
Kawano, O.1
Sasaki, H.2
Endo, K.3
-
27
-
-
79953024710
-
Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer
-
Ludovini V, Bianconi F, Pistola L, et al. Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer. J Thorac Oncol. 2011;6(4): 707-715.
-
(2011)
J Thorac Oncol
, vol.6
, Issue.4
, pp. 707-715
-
-
Ludovini, V.1
Bianconi, F.2
Pistola, L.3
-
28
-
-
34548446446
-
PIK3CA mutation and amplification in human lung cancer
-
Okudela K, Suzuki M, Kageyama S, et al. PIK3CA mutation and amplification in human lung cancer. Pathol Int. 2007;57(10): 664-671.
-
(2007)
Pathol Int
, vol.57
, Issue.10
, pp. 664-671
-
-
Okudela, K.1
Suzuki, M.2
Kageyama, S.3
-
29
-
-
11144358645
-
High frequency of mutations of the PIK3CA gene in human cancers
-
doi:10.1126/science.1096502
-
Samuels Y, Wang Z, Bardelli A, et al. High frequency of mutations of the PIK3CA gene in human cancers. Science. 2004;304(5670): 554. doi:10.1126/science. 1096502.
-
(2004)
Science
, vol.304
, Issue.5670
, pp. 554
-
-
Samuels, Y.1
Wang, Z.2
Bardelli, A.3
-
30
-
-
84856823963
-
Coexistence of PIK3CA and other oncogene mutations in lung adenocarcinoma-rationale for comprehensive mutation profiling
-
Chaft JE, Arcila ME, Paik PK, et al. Coexistence of PIK3CA and other oncogene mutations in lung adenocarcinoma-rationale for comprehensive mutation profiling. Mol Cancer Ther. 2012;11(2): 485-491.
-
(2012)
Mol Cancer Ther
, vol.11
, Issue.2
, pp. 485-491
-
-
Chaft, J.E.1
Arcila, M.E.2
Paik, P.K.3
|